scholarly article | Q13442814 |
P2093 | author name string | Christopher A Blair | |
Xiaolin Zi | |||
P2860 | cites work | Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. | Q34658356 |
Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer | Q35024933 | ||
Drug insight: role of the androgen receptor in the development and progression of prostate cancer | Q36773464 | ||
The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags | Q37089379 | ||
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance | Q37145531 | ||
Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target | Q37606741 | ||
Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy | Q38349983 | ||
Novel splice variant CAR 4/6 of the coxsackie adenovirus receptor is differentially expressed in cervical carcinogenesis | Q39571698 | ||
Osteopontin-c splicing isoform contributes to ovarian cancer progression. | Q39603458 | ||
Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression | Q39605639 | ||
Antisense inhibition of survivin expression as a cancer therapeutic | Q39610362 | ||
Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line. | Q39787201 | ||
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study | Q24643018 | ||
A census of human cancer genes | Q24647081 | ||
Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences | Q24682430 | ||
Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications | Q24682555 | ||
Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing | Q24798935 | ||
A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth | Q28116222 | ||
Genetic therapies for RNA mis-splicing diseases | Q28235690 | ||
Alternative splicing: increasing diversity in the proteomic world | Q29618730 | ||
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer | Q30485336 | ||
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant | Q30495758 | ||
Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis | Q33182439 | ||
Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth. | Q33658256 | ||
Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology | Q34084341 | ||
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor | Q34165500 | ||
Systemic administration of PRO051 in Duchenne's muscular dystrophy | Q34172661 | ||
Anti-tumor activity of splice-switching oligonucleotides | Q34401490 | ||
The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy | Q34473336 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 836-839 | |
P577 | publication date | 2011-11-01 | |
P1433 | published in | Indian Journal of Experimental Biology | Q2622243 |
P1476 | title | Potential molecular targeting of splice variants for cancer treatment | |
P478 | volume | 49 |
Q39163794 | Adult T-cell leukemia cells are characterized by abnormalities of Helios expression that promote T cell growth |
Q26852848 | Alternative splicing for diseases, cancers, drugs, and databases |
Q37240124 | Analysis of protein isoforms: can we do it better? |
Q39393155 | Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact |
Q36877029 | Review: Alternative Splicing (AS) of Genes As An Approach for Generating Protein Complexity. |
Q49473342 | Splice variants of the endonucleases XPF and XPG contain residual DNA repair capabilities and could be a valuable tool for personalized medicine |
Q35076912 | TIPMaP: a web server to establish transcript isoform profiles from reliable microarray probes |
Search more.